Cardiopulmonary bypass considerations for pediatric patients on the ketogenic diet

R W Melchior1, M Dreher2, E Ramsey3

  • 1Department of Perfusion Services, The Children's Hospital of Philadelphia, Philadelphia, PA, USA melchiorr@email.chop.edu.

Perfusion
|November 9, 2014
PubMed

Insights

Children with epilepsy on a ketogenic diet require special care during heart surgery. Modified protocols are essential to maintain ketosis and prevent seizures in these patients undergoing cardiopulmonary bypass (CPB).

Area of Science:

  • Pediatric Cardiology
  • Neurology
  • Metabolic Disorders

Background:

  • Intractable epilepsy in children often necessitates alternative treatments like the ketogenic diet.
  • The ketogenic diet, a high-fat, low-carbohydrate regimen, is effective in reducing seizure frequency.
  • Children on ketogenic diets undergoing cardiopulmonary bypass (CPB) require specialized protocols to avoid glucose exposure and maintain ketosis.

Observation:

  • A 2-year-old male with intractable epilepsy and congenital heart disease underwent cardiac surgery.
  • The surgical team implemented modified protocols, minimizing carbohydrate-containing medications.
  • Metabolic monitoring was crucial to ensure the patient's ketosis was maintained throughout the procedure.

Findings:

  • Successful cardiac surgery was performed on a pediatric patient maintained on a ketogenic diet.
  • Adherence to modified protocols and vigilant metabolic monitoring prevented alterations in ketosis.
  • The case demonstrates the feasibility of managing ketogenic diet patients during CPB.

Implications:

  • Cardiac surgical teams must be aware of ketogenic diet patients and adapt protocols accordingly.
  • Multidisciplinary collaboration is key for optimizing care, including modified CPB prime components and cardiac pharmacology.
  • Advanced monitoring techniques like thromboelastography, electroencephalography, and continuous glucose monitoring are recommended for this patient population.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
7
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
1
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518